Green tea Camellia sinensis
Also called: green tea extract
Green tea is made from leaves of the tea plant, Camellia sinensis, that are steamed, pan fried and dried but not fermented. It is consumed as a beverage and sold as concentrated extracts in tablets and capsules.
- Category
- Botanical
- Part used
- Leaf (beverage or concentrated extract)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2020 meta-analysis (Nutr J) pooled 31 RCTs (3,321 subjects) of green tea beverages or extracts on blood lipids; trials giving green tea extract as part of a multicomponent supplement were excluded. [4]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
CBlood sugar and weight1 topic
CCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Total and LDL cholesterol in adults | B | A meta-analysis of randomized, placebo-controlled trials, mostly of extract supplements, found small reductions in total and LDL cholesterol and no effect on HDL cholesterol or triglycerides. [1] |
| Body weight | C | NCCIH reports that catechins and caffeine may have a modest effect, and that results may vary with product composition and physical activity. [1] |
| Coronary heart disease risk | C | A meta-analysis of cohort (observational) studies linked green tea drinking to lower risk in Asian populations but not in Western populations. [1] |
| Cancer risk | C | Many studies, summarized in a Cochrane systematic review, have examined green tea and cancer risk; results are inconsistent. [1] |
Main constituents: Catechins, about 10% of extracts; epigallocatechin-3-gallate (EGCG) is the most concentrated [2]; Caffeine [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Mean daily EGCG intake from green tea infusions ranges from 90 to 300 mg/day (EFSA, 2018). [3]
- Single doses of up to 1.6 g of extract were well tolerated in humans; the reported maximum tolerated dose was 9.9 g per day, about 24 cups of tea. Long-term safety is not well defined. [2]
Upper limits
- EFSA (2018): intake of 800 mg EGCG/day or more taken as a food supplement has been shown to induce a statistically significant increase of serum transaminases; the Panel could not identify an EGCG dose from green tea extracts that could be considered safe. [3]
Safety and side effects
- Liver (NIH LiverTox)Score AABCDEA: well known causeE: unlikely cause
LiverTox likelihood score A (well established cause of clinically apparent liver injury), chapter last updated November 20, 2020.
Details and sources - Pregnancy and breastfeedingNCCIH: caffeine intake in pregnancy should not exceed moderate levels …
2 statements in the profile.
Details and sources - Interactions with medicines3 listed
Nadolol; Atorvastatin; Raloxifene
Details and sources - Cancer evaluations (IARC, NTP)2 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications4 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada (monograph dated July 25, 2025), adults 18 and older, standardized extracts: not to exceed 690 mg total catechins per day, including a …
Details and sources
- No safety concerns have been reported for green tea consumed as a beverage by adults; it contains caffeine. [1]
- Liver injury has been reported, mainly with extracts in tablet or capsule form. People with a specific immune-related gene variant (5 to 15 percent of Americans) appear especially susceptible. [1]
- LiverTox likelihood score A (well established cause of clinically apparent liver injury); more than 100 cases reported, usually 1 to 6 months after starting, with a hepatocellular pattern; fatal acute liver failure has occurred. [2]
- In one prospective study of postmenopausal women, ALT elevations occurred in 6.7% of those taking green tea extract versus 0.7% of controls. [2]
- Extract side effects include nausea, constipation, abdominal discomfort and increased blood pressure. [1]
- Pregnancy: caffeine intake should not exceed moderate levels. Breastfeeding: caffeine passes into breast milk; high intake can make infants fussy and disrupt their sleep. [1]
Interactions
| With | What happens |
|---|---|
| Nadolol | Green tea at high doses has been shown to reduce blood levels of this beta-blocker, which may reduce its effectiveness. [1] |
| Atorvastatin | Green tea extract can reduce blood levels of this cholesterol-lowering drug. [1] |
| Raloxifene | An NCCIH-funded study found that green tea interacts with this osteoporosis drug. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Concentrations of extract, EGCG and other components vary widely among marketed products; this variability may explain why only some products have caused liver injury. [2]
Regulatory status
- US: sold as a dietary supplement ingredient; dietary supplements are not approved by the FDA before sale, and manufacturers are responsible for safety and labeling. [1]
- US: a specific green tea extract ointment is FDA-approved as a prescription drug for external genital and perianal warts. [1]
- EU: EFSA's 2018 opinion concluded that catechins from traditionally prepared infusions are in general considered safe, but found transaminase increases at 800 mg EGCG/day or more from food supplements. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Catechins (about 10% of green tea extract); epigallocatechin-3-gallate (EGCG) is present in highest concentration Polyphenols (catechins) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 4 entries naming Camellia sinensis (green tea) (earliest NDI 454 submitted 2007-03-07; most recent NDI 1055 submitted 2017-12-03). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- IARC: 'Tea' is classified in Group 3 (not classifiable as to its carcinogenicity to humans), IARC Monographs Volume 51 (1991); the IARC list has no separate entry for green tea extract. [P4]
- NTP TR-585 (2016), green tea extract by gavage for 2 years: no evidence of carcinogenic activity in male or female Wistar Han rats (100, 300 or 1,000 mg/kg) or in male or female B6C3F1/N mice (30, 100 or 300 mg/kg). [P2]
Liver (NIH LiverTox)
Interactions with medicines
- Nadolol: Green tea at high doses has been shown to reduce blood levels of this beta-blocker, which may reduce its effectiveness. [P5]
- Atorvastatin: Green tea extract can reduce blood levels of this cholesterol-lowering drug. [P5]
- Raloxifene: An NCCIH-funded study found that green tea interacts with this osteoporosis drug. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- HPLC analysis of seven commercial green tea products (extracts or tea bags) found catechin content ranging from 9% to 48% of label claims, all significantly lower than claimed (Manning and Roberts, 2003). [P7]
- LiverTox: there is great variability in the concentration of green tea extract, EGCG and other components among marketed products. [P1]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P8]
- Catechin and EGCG assay (e.g., HPLC) against label claim — Measured catechin content of seven commercial products ranged from 9% to 48% of label claims (Manning and Roberts, 2003). [P7]
- Caffeine and total catechin content — Health Canada's monograph sets daily limits expressed as total catechins, EGCG and caffeine (not to exceed 690 mg total catechins, 300 mg EGCG and 150 mg caffeine per day for the antioxidant use). [P9]
Supply and conservation
- IUCN Red List: Data Deficient (DD), via GBIF species API, retrieved 2026-10-29. [P10]
Absorption in people
- EFSA (2018): taking green tea extract under fasting conditions and as a bolus leads to a significant increase in the plasma AUC of EGCG compared with taking it with food or in split doses; plasma contains intact EGCG and ECG and several catechin metabolites. [P6]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada (monograph dated July 25, 2025), adults 18 and older, standardized extracts: not to exceed 690 mg total catechins per day, including a maximum of 300 mg EGCG, and not to exceed 150 mg caffeine per day (antioxidant use); to be taken with a meal. [P9]
Pregnancy and breastfeeding
- NCCIH: caffeine intake in pregnancy should not exceed moderate levels; caffeine passes into breast milk, and high intake can make infants fussy and disrupt their sleep. [P5]
- Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding; products for weight management are contraindicated in pregnancy. [P9]
Sources for this profile
- NIH LiverTox. Green Tea (last update November 20, 2020), 2020-11-20. ncbi.nlm.nih.gov
- National Toxicology Program. TR-585: Toxicology Studies of Green Tea Extract in F344/NTac Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Green Tea Extract in Wistar Han Rats and B6C3F1/N Mice (Gavage Studies) (report date April 2016), abstract, 2016-04. ntp.niehs.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- NCCIH. Green Tea (Last Updated: February 2025), 2025-02. nccih.nih.gov
- EFSA ANS Panel. Scientific opinion on the safety of green tea catechins. EFSA Journal 2018;16(4):5239, 2018-04-18. pmc.ncbi.nlm.nih.gov
- Manning J, Roberts JC. Analysis of catechin content of commercial green tea products. J Herb Pharmacother 2003;3(3):19-32 (PMID 15277054), 2003. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Health Canada, NNHPD. Monograph: Green Tea Extract (date 2025-07-25), 2025-07-25. webprod.hc-sc.gc.ca
- GBIF species API: IUCN Red List category for Camellia sinensis (L.) Kuntze, 2026-10-29. api.gbif.org
Sources
- NCCIH. Green Tea (Last Updated: February 2025), 2025-02. nccih.nih.gov
- NIH LiverTox. Green Tea (last update November 20, 2020), 2020-11-20. ncbi.nlm.nih.gov
- EFSA ANS Panel. Scientific opinion on the safety of green tea catechins. EFSA Journal 2018;16(4):5239, 2018-04-18. pmc.ncbi.nlm.nih.gov
- Xu R, et al. Effect of green tea consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr J 2020;19(1):48 (PMID 32434539), 2020-05-20. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.